Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Pipeline
Amgen Science
Amgen Competitive Grants
Biosimilars
Overview
About Clinical Trails
Amgen Clinical Trails
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
Corporate Responsibility
Strategy & Governance
Overview
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Transformative Treatments, Approaches, and Technology
Access to Medicine
Amgen Foundation
Overview
Amgen Inspires
Amgen Foundation Grants
About the Amgen Foundation
Commitment to Community
Overview
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients
Diversity, Inclusion and Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Overview
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Workplace
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
Newsroom
Investors
Careers
Overview
Amgen History
Mission and Values
Leadership
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Overview
Overview <i class="fa fa-external-link"></i>
Pipeline <i class="fa fa-external-link"></i>
Amgen Competitive Grants <i class="fa fa-external-link"></i>
Scientific Community Initiatives
Overview
Innovation
Quality
Reliability
Overview
Medical Information
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Overview
Corporate Responsibility <span class="mobile-menu-break"></span>Strategy & Governance
Our Approach to Pricing, <span class="mobile-menu-break"></span>Access and Affordability
Access to Medicine
Amgen Foundation
Commitment to Community
Diversity, Inclusion and Belonging
Environment
Responsible Sourcing
Workplace
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
About Amgen
Overview
Amgen in the Netherlands
Missie & Waarden
Our vision
Transparency
The history of Amgen
Therapeutic areas
Contact
Science
Overview
Amgen pipeline
Introduction in biotechnology
Immuno-oncology: The next generation of cancer treatment
Clinical research
Amgen biosimilars
Biomarkers: The key to transforming lung cancer treatment
Products
Overview
Our medicines
Our outcome based solutions
Value solutions
Care solutions
Amgen biosimilars
Medical information
Responsibility
Overview
Amgen Foundation
Code VIG
Stories
Working at Amgen
Media
DUTCH
X
Home
>
Stories
>
All Stories
Responsibility
02.16.2021
Round table with national and local politicians on Amgen's impact on the local economy
Read more
All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>
All
PATIENTS
Outcome based solutions
Responsibility
All
PATIENTS
Outcome based solutions
Responsibility
Responsibility
12.27.2022
8 Ways $30 Million from Amgen Foundation Commitment Will Improve STEM Education Globally
Responsibility
12.12.2022
Healthcare Businesswomen's Association and Amgen: together we make each other stronger
Responsibility
12.11.2022
Report on our progress in Environmental, Social & Governance Society
Responsibility
04.13.2022
Coming up: Working Session Value Agenda NL
Responsibility
03.13.2022
Round table with national and local politicians on Amgen's impact on the local economy
Responsibility
03.13.2022
Surprising Easter brunch by Amgen for participants of De Zonnebloem
Outcome based solutions
03.08.2022
Hooray, the AmgenCare program celebrates its 20th anniversary!
Responsibility
08.03.2021
Breda Singelloop and main sponsor Amgen extend contract for 5 years
Responsibility
08.03.2021
Amgen 2021 surprises 619 Zonnebloem participants in Breda with a Christmas gift
Responsibility
08.03.2021
Fietselfstedentocht: Amgen cycles eleven cities for Stichting Matchis
Responsibility
08.13.2020
Annual toy donation for Voedselbank Breda
PATIENTS
08.03.2020
"100 times better" a home treatment for cancer
Load more
Loading...